全文获取类型
收费全文 | 1016768篇 |
免费 | 78647篇 |
国内免费 | 4062篇 |
专业分类
耳鼻咽喉 | 13086篇 |
儿科学 | 34678篇 |
妇产科学 | 28655篇 |
基础医学 | 147826篇 |
口腔科学 | 28069篇 |
临床医学 | 93267篇 |
内科学 | 196520篇 |
皮肤病学 | 23115篇 |
神经病学 | 80192篇 |
特种医学 | 39100篇 |
外国民族医学 | 318篇 |
外科学 | 151502篇 |
综合类 | 27659篇 |
现状与发展 | 5篇 |
一般理论 | 385篇 |
预防医学 | 78893篇 |
眼科学 | 23162篇 |
药学 | 74123篇 |
24篇 | |
中国医学 | 3210篇 |
肿瘤学 | 55688篇 |
出版年
2018年 | 11353篇 |
2017年 | 8922篇 |
2016年 | 10060篇 |
2015年 | 11628篇 |
2014年 | 15677篇 |
2013年 | 23044篇 |
2012年 | 30541篇 |
2011年 | 32559篇 |
2010年 | 19500篇 |
2009年 | 18219篇 |
2008年 | 29839篇 |
2007年 | 31470篇 |
2006年 | 32024篇 |
2005年 | 30676篇 |
2004年 | 29609篇 |
2003年 | 28404篇 |
2002年 | 27337篇 |
2001年 | 47367篇 |
2000年 | 48503篇 |
1999年 | 40746篇 |
1998年 | 11472篇 |
1997年 | 10390篇 |
1996年 | 10361篇 |
1995年 | 9973篇 |
1994年 | 9305篇 |
1993年 | 8595篇 |
1992年 | 32367篇 |
1991年 | 31575篇 |
1990年 | 31121篇 |
1989年 | 29957篇 |
1988年 | 27248篇 |
1987年 | 27397篇 |
1986年 | 25490篇 |
1985年 | 24655篇 |
1984年 | 18417篇 |
1983年 | 15525篇 |
1982年 | 9300篇 |
1981年 | 8389篇 |
1979年 | 16873篇 |
1978年 | 12219篇 |
1977年 | 10316篇 |
1976年 | 9757篇 |
1975年 | 10178篇 |
1974年 | 12320篇 |
1973年 | 11843篇 |
1972年 | 10884篇 |
1971年 | 10113篇 |
1970年 | 9375篇 |
1969年 | 8724篇 |
1968年 | 8104篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
Stelter K. Theodoraki M. N. Becker S. Tsekmistrenko V. Olzowy B. Ledderose G. 《European archives of oto-rhino-laryngology》2015,272(3):639-639
European Archives of Oto-Rhino-Laryngology - 相似文献
65.
66.
F. Giovanardi F. Nudo Q. Lai M. Garofalo A. Consolo E. Choppin De Janvry G.A. Arroyo Murillo P. Ursi D. Stabile F. Melandro P.B. Berloco R. Pretagostini L. Poli 《Transplantation proceedings》2019,51(1):128-131
Background
Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.Methods
During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.Results
No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.Conclusions
The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach. 相似文献67.
68.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
69.
70.